ZYNRELEF

Heron Therapeutics, Inc.🇺🇸 United States

FDA Page

Effective Date: May 30, 2025
Approval ID: dab484a7-9353-43ba-9e74-7fab910c712b
Products: 8 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ZYNRELEF safely and effectively. See full prescribing information for ZYNRELEF. ZYNRELEF (bupivacaine and meloxicam) extended-release solution, for instillation use Initial U.S. Approval: 2021

Quick Stats

Total Products8

Labelers2

Label Sections54

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.